- Home
- SINT vs VYNE Comparison
SINT vs VYNE Comparison
Compare SINT & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SINT | VYNE |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 12.5M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SINT | VYNE |
|---|---|---|
| Price | $3.65 | $0.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 70.3K | ★ 14.9M |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,270,000.00 | $524,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $80.00 | $16.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.29 |
| 52 Week Low | $1.71 | $0.28 |
| 52 Week High | $7.36 | $4.30 |
Technical Indicators
Market Signals| Indicator | SINT | VYNE |
|---|---|---|
| Relative Strength Index (RSI) | 51.50 | 64.96 |
| Support Level | $3.49 | $0.56 |
| Resistance Level | $3.83 | $0.59 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 36.71 | 51.52 |
Price Performance
Historical ComparisonAbout SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.